
Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer
Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present i
Updated on: November 19,2023
18

Universal genetic testing may improve risk stratification and treatment for rare and lethal cancer
Esophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20 percent. Although a precursor lesion to EAC, called Barrett's esophagus (BE), is present i
Updated on:November 19,2023
18
